Golden

Merck

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn
+ Add new row

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

News

Title
Author
Date
Publisher
Description
February 14, 2020
WebWire
The Democratic Republic of the Congo (DRC), Burundi, Ghana and Zambia have licensed an Ebola vaccine, just 90 days after World Health Organization (WHO) prequalification. Registration of the vaccine is expected in additional countries in the coming weeks. The licensing of the vaccine means that the manufacturer can stockpile and widely distribute this vaccine to African countries at risk of Ebola virus disease outbreaks. Once licensed doses are available, use of the vaccine will not requi...
Reuters
January 4, 2020
@bsindia
Read more about Novartis, Merck, Allergan raise US prices, 445 drugs to cost more in 2020 on Business Standard. That is above the average of 404 drug price increases in the first three days of January over the past five years
Michael Erman
January 3, 2020
U.S.
Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020, according to data analyzed by healthcare research firm 3 Axis Advisors.
Pushkala Aripaka
December 30, 2019
IN
AstraZeneca and Merck's ovarian cancer drug Lynparza has received U.S. regulatory approval for the treatment of advanced pancreatic cancer, cementing its lead in a niche category of cancer treatments.
Max Nisen | Bloomberg
December 25, 2019
@bsindia
Read more about Gene therapy to conquering hepatitis C: A decade of medical breakthroughs on Business Standard. Putting aside prices for a moment, it's been an exciting period for medical progress
Helen Branswell
December 20, 2019
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
Reuters Editorial
December 20, 2019
IN
The U.S. Food and Drug Administration said on Thursday it granted approval to drugmaker Merck & Co's Ebola vaccine Ervebo, making it the first FDA-approved vaccine against the deadly virus.
Ben Winck
December 9, 2019
markets.businessinsider.com
A cancer-drug developer's stock just surged more than 100% after Merck agreed to a multi-billion-dollar takeover
Reuters Editorial
November 14, 2019
IN
Health authorities in eastern Congo have introduced a new Ebola vaccine produced by Johnson & Johnson, aid group MSF said on Thursday, to help combat the world's second-worst outbreak of the virus on record.
Beth Mole
November 13, 2019
Ars Technica
The WHO wasted no time to "prequalifying" the newly approved vaccine.
Helen Branswell
November 12, 2019
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
Reuters
October 30, 2019
@bsindia
Read more about Wall Street holds steady after S&P hits record; Merck, Pfizer stocks gain on Business Standard. The spread in the yield curve has gainedabout 20 basis points since leaving negative territory, a recession indicator, in early September
Reuters Editorial
October 13, 2019
IN
Health authorities in Democratic Republic of Congo will introduce a Johnson & Johnson Ebola vaccine in November in the country's eastern provinces, to counter the current outbreak, they said.
Thor Olavsrud
October 7, 2019
CIO
Merck's core IT infrastructure team took the lead in helping the business innovate by exploring the transformative power of 3D printing.
Emily Baumgaertner
July 25, 2019
Los Angeles Times
Merck's Ebola vaccine was once expected to function as a silver bullet. But now its supply is dwindling, and it's likely to burn out before the outbreak does.
Manas Mishra
July 30, 2019
U.S.
Merck & Co Inc reported better-than-expected second-quarter results on Tuesday and raised its full-year earnings forecast on strong demand for its blockbuster cancer immunotherapy Keytruda and vaccines.
Donald G. McNeil Jr.
July 23, 2019
www.nytimes.com
In preliminary tests, a matchstick-size rod containing a new drug offered promise as a shield against the virus. But a large clinical trial must still be done.
Denise Grady
July 17, 2019
www.nytimes.com
The World Health Organization issued the order; the virus has infected more than 2,500 people and killed nearly 1,700.
Reuters Editorial
June 13, 2019
U.S.
IBM, Merck and Walmart have been chosen for a U.S. Food and Drug Administration pilot program that will explore using blockchain technology to improve the security of prescription drug supply and distribution.
Sinéad Carew
June 3, 2019
U.S.
The Nasdaq tumbled 1.6% on Monday, confirming a correction as it was dragged down by Alphabet, Facebook and Amazon.com on fears the companies are the targets of U.S. government antitrust regulators.
SHOW MORE